Goxalapladib is a 5-HT6 receptor modulator that blocks lipoprotein-associated phospholipase A2 (Lp-PLA2) activity. Goxalapladib is promising for research of atherosclerosis-associated cardiovascular diseases[1].
Molecular Weight:
718.75
CAS Number:
[412950-27-7]
Formula:
C40H39F5N4O3
Target:
5-HT Receptor,Phospholipase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted